Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03733405 · ClinicalTrials.gov registry record · NA
Postpartum Care Timing: A Randomized Trial
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 256
- Enrollment target
NCT03733405: Completed NA study, sponsored by University of California, Los Angeles.
NCT03733405 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 256 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03733405, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 256 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if shortening the time to initial postpartum visit from six weeks to two weeks can improve clinic visit attendance and decrease usage of the emergency department.
Primary Outcome
The primary outcome will be the attendance at one or more scheduled postpartum visits at the clinic where the patient received her prenatal care.
Interventions
- BEHAVIORAL Postpartum Visit at 6 Weeks
- BEHAVIORAL Postpartum Visit at 2 Weeks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2018-10-31 |
| Est. Completion | 2020-07-01 |
| Phase | NA |
What the finished NCT03733405 record still lists
NCT03733405 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Postpartum Visit at 6 Weeks is the first listed.
NCT03733405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03733405 about?
NCT03733405 is a clinical study titled "Postpartum Care Timing: A Randomized Trial". The purpose of this study is to determine if shortening the time to initial postpartum visit from six weeks to two weeks can improve clinic visit attendance and decrease usage of the emergency department.
What is the current status of trial NCT03733405?
This trial is currently completed. It is a NA study. The enrollment target is 256 participants. The study started on 2018-10-31. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT03733405?
The interventions under investigation include: Postpartum Visit at 6 Weeks (BEHAVIORAL), Postpartum Visit at 2 Weeks (BEHAVIORAL).
Who is sponsoring clinical trial NCT03733405?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03733405's enrollment target sits among peer trials
256 404th of 2000 higher than 1,594 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI